MBTPS1 and metabolic dysfunction-associated steatohepatitis: These data establish a mechanistic link between S1P/S1P receptor signaling and the immune inflammatory response in NASH, as selective inhibition of S1P receptors demonstrated reversal of adverse features of NASH.